Tahir Suleymanov

Prof. Tahir Suleymanov

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
TSTahir Suleymanov
Tahir Suleymanov
EBEmilya Balayeva
Emilya Balayeva
NANA Kubra Aliyeva
NA Kubra Aliyeva
BSBehrouz Seyfinejad
Behrouz Seyfinejad
Abolghasem JouybanAbolghasem Jouyban
Abolghasem Jouyban
ABAytac Badalova
Aytac Badalova
Levofloxacin (LVX) is a broad-spectrum antibiotic whose systemic administration can be limited by adverse effects and suboptimal drug levels at infection sites. Implantable drug-loaded meshes offer a promising strategy for localized, prolonged delivery. This study developed and validated a simple, rapid, and reliable high-performance liquid chromatography with ultraviolet detection (HPLC-UV) method for quantifying LVX in rat blood to support the preclinical evaluation of a prolonged-release LVX-loaded polypropylene mesh. The method utilized a Zorbax SB-C18 column with an isocratic mobile phase of acetonitrile:0.1% orthophosphoric acid (80:20, v/v) at a flow rate of 1.4 mL/min, with detection at 296 nm. Validation according to ICH Q2(R2) guidelines demonstrated excellent linearity (R² = 0.999) over 1–8 µg/mL, accuracy (mean recovery 99.68%), and precision (intra- and inter-day CV < 0.3%). The limits of detection and quantification were 0.3 µg/mL and 1.0 µg/mL, respectively. The validated method was successfully applied to quantify LVX in rat plasma samples collected over 10 days post-implantation, confirming its suitability for pharmacokinetic studies of implant-based antibiotic delivery systems. This method provides a practical and robust analytical tool for routine preclinical assessment of LVX release and systemic exposure from localized delivery devices.

5 March 2026 in Molecules
Verified
Journal Article
Open access
PDF file
TSTahir Suleymanov
Tahir Suleymanov
EBEmilya Balayeva
Emilya Balayeva
EGElnur Gasimov
Elnur Gasimov
ABAytac Badalova
Aytac Badalova
NANA Kubra Aliyeva
NA Kubra Aliyeva
A simple, rapid, and cost-effective UV–Vis spectrophotometric method was developed and validated for the determination of levofloxacin in rat plasma to support the evaluation of a novel antimicrobial mesh implant containing levofloxacin, chitosan, gelatin, tinctura propolis, citric, acid and glycerin. Plasma samples were treated with 0.1 M HCl, and absorbance was measured at 290 nm. The method was validated according to FDA and ICH guidelines, including assessments of linearity, sensitivity, accuracy, precision, and specificity. The calibration curve was linear over the concentration range of 2.5–12.5 μg/mL (R2 = 0.999, p < 0.001). The limit of detection and limit of quantification were 0.21 μg/mL and 0.62 μg/mL, respectively. Intra- and inter-day precision showed low relative standard deviation values (0.2% and 0.25%), while recovery ranged from 94.8% to 96.4%, confirming acceptable accuracy. No significant interference from plasma matrix components was observed. Compared with chromatographic techniques, the proposed method provides an accessible alternative for routine bioanalysis and therapeutic monitoring. The validated assay is suitable for assessing prolonged levofloxacin release from implantable drug delivery systems in preclinical studies.

14 July 2026 in Liquids
Verified
Journal Article
Open access
PDF file
Daniel Ricardo DelgadoDaniel Ricardo Delgado
Daniel Ricardo Delgado
Fleming MartinezFleming Martinez
Fleming Martinez
Mª Ángeles Peña FernándezMª Ángeles Peña Fernández
Mª Ángeles Peña Fernández
TSTahir Suleymanov
Tahir Suleymanov
Abolghasem JouybanAbolghasem Jouyban
Abolghasem Jouyban
William E. AcreeWilliam E. Acree
William E. Acree
The main objective of this research was to determine and correlate the equilibrium solubility of sodium sulfamethazine (NaSMT) in several {ethanol (1) + water (2)} mixtures reported in mass/volume and mass/mass percentages at different temperatures, as well as the density of saturated solutions. NaSMT solubility decreases with decreasing temperature, and also decreases non-linearly with the addition of ethanol to water at every temperature. Logarithmic solubility was adequately correlated with a bivariate model involving temperature and mixture composition. Solubility values were also well correlated with some Jouyban–Acree-based models. Moreover, an adapted version of the Jouyban–Acree model was used to represent the density of the saturated systems at different temperatures. Furthermore, the apparent specific volumes of NaSMT at saturation were also calculated from densities of saturated solutions and cosolvent mixtures free of drug at every mixture composition and temperature. These findings provide valuable insights into the solubility and volumetric behavior of NaSMT that could be useful for improving pharmaceutical formulation processes.